Skip to content
BIO 2025: The innovation race vs. the regulatory pace
We often talk about the exciting jumps in technology and innovation that improve ...
Read More
BIO 2025: The world can’t wait – it needs to collaborate
Biotech is a global business, and we’re better for it, said experts at ...
Read More
Alzheimer’s Awareness Month: What to know about a disease impacting millions
Over 7 million Americans live with Alzheimer’s disease, according to the Alzheimer’s Association. ...
Read More
BIO 2025: What is the PRV program and why does it matter?
Established in 2012, the Pediatric Priority Review (PPRV) program offers a powerful incentive ...
Read More
BIO 2025: Health equity as an engine for scalable innovation
Health equity should not be considered a parallel initiative, but a central pillar ...
Read More
BIO 2025: ‘Behind every data point there is a person’
The 2025 Biotechnology Innovation Organization (BIO) International Convention highlighted why we – the ...
Read More
EDITORS' CHOICE
Pennsylvania’s Gov. Shapiro courts biotechs at BIO 2025
Pennsylvania is open for biotech business and working hard to grow the life sciences ecosystem that already exists in the state, according to Gov. Josh ...
Read More
LATEST NEWS
BIO Events
BIO 2025: The innovation race vs. the regulatory pace
We often talk about the exciting jumps in technology and innovation that improve and save lives. What is less frequently discussed is how regulation has ...
BIO Events
BIO 2025: The world can’t wait – it needs to collaborate
Biotech is a global business, and we’re better for it, said experts at the 2025 Biotechnology Innovation Organization (BIO) International Convention in Boston. International cooperation ...
Health
Alzheimer’s Awareness Month: What to know about a disease impacting millions
Over 7 million Americans live with Alzheimer’s disease, according to the Alzheimer’s Association. For June’s Alzheimer’s Awareness Month, Bio.News sat down with the Alzheimer’s Association ...
BIO Events
BIO 2025: What is the PRV program and why does it matter?
Established in 2012, the Pediatric Priority Review (PPRV) program offers a powerful incentive for companies to develop treatments for rare conditions affecting children. Even though ...
BIO Events
BIO 2025: Health equity as an engine for scalable innovation
Health equity should not be considered a parallel initiative, but a central pillar of the biotech industry’s strategy, said experts on Day 3 of the ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
AGRICULTURE
Climate Change
Combatting misinformation on biotechnology in food
Biotechnology’s role in enhancing food security while addressing climate change is gaining deserved attention. It is important that we understand ...
Read More
Federal Policy
State Policy
BIO 2025: A few highlights from Day 2
George W. Bush, 43rd President of the United States, headlined Tuesday’s mainstage with an exclusive conversation with Biotechnology Innovation Organization ...
Read More
International
Bio's View
BIO 2025: Rare disease patients can’t wait
The rare disease patient community is the beating heart of the Biotechnology Innovation Organization’s (BIO) mission. Whether it is driving ...
Read More
